{"id":"https://openalex.org/W4281745809","doi":"https://doi.org/10.1111/bcpt.13759","title":"Application of Emax model to assess the potency of topical corticosteroid products","display_name":"Application of Emax model to assess the potency of topical corticosteroid products","alternate_titles":[],"publication_year":2022,"publication_date":"2022-05-31","ids":{"openalex":"https://openalex.org/W4281745809","doi":"https://doi.org/10.1111/bcpt.13759","pmid":"https://pubmed.ncbi.nlm.nih.gov/35639025"},"language":"en","primary_location":{"id":"doi:10.1111/bcpt.13759","doi":"https://doi.org/10.1111/bcpt.13759","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcpt.13759","pdf_url":null,"source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4281745809"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031518410","display_name":"Seeprarani Prabirkumar Rath","orcid":"https://orcid.org/0000-0003-2216-1238","observed_orcids":["https://orcid.org/0000-0003-2216-1238"]},"institutions":[{"id":"https://openalex.org/I203238179","display_name":"Rhodes University","ror":"https://ror.org/016sewp10","country_code":"ZA","type":"education","lineage":["https://openalex.org/I203238179"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Seeprarani Rath","raw_affiliation_strings":["Biopharmaceutics Research Institute, Rhodes University, Grahamstown, South Africa"],"raw_orcid":"https://orcid.org/0000-0003-2216-1238","affiliations":[{"raw_affiliation_string":"Biopharmaceutics Research Institute, Rhodes University, Grahamstown, South Africa","institution_ids":["https://openalex.org/I203238179"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043595351","display_name":"Michael Zvidzayi","orcid":"https://orcid.org/0000-0002-8177-9268","observed_orcids":["https://orcid.org/0000-0002-8177-9268"]},"institutions":[{"id":"https://openalex.org/I203238179","display_name":"Rhodes University","ror":"https://ror.org/016sewp10","country_code":"ZA","type":"education","lineage":["https://openalex.org/I203238179"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Michael Zvidzayi","raw_affiliation_strings":["Biopharmaceutics Research Institute, Rhodes University, Grahamstown, South Africa"],"raw_orcid":"https://orcid.org/0000-0002-8177-9268","affiliations":[{"raw_affiliation_string":"Biopharmaceutics Research Institute, Rhodes University, Grahamstown, South Africa","institution_ids":["https://openalex.org/I203238179"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048706653","display_name":"Charles Bon","orcid":"https://orcid.org/0000-0002-9414-160X","observed_orcids":["https://orcid.org/0000-0002-9414-160X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles Bon","raw_affiliation_strings":["Biostudy Solutions LLC, Wilmington, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0002-9414-160X","affiliations":[{"raw_affiliation_string":"Biostudy Solutions LLC, Wilmington, North Carolina, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080330665","display_name":"Isadore Kanfer","orcid":"https://orcid.org/0000-0002-4194-4273","observed_orcids":["https://orcid.org/0000-0002-4194-4273"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I203238179","display_name":"Rhodes University","ror":"https://ror.org/016sewp10","country_code":"ZA","type":"education","lineage":["https://openalex.org/I203238179"]}],"countries":["CA","ZA"],"is_corresponding":true,"raw_author_name":"Isadore Kanfer","raw_affiliation_strings":["Biopharmaceutics Research Institute, Rhodes University, Grahamstown, South Africa","Leslie Dan College of Pharmacy, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":"https://orcid.org/0000-0002-4194-4273","affiliations":[{"raw_affiliation_string":"Biopharmaceutics Research Institute, Rhodes University, Grahamstown, South Africa","institution_ids":["https://openalex.org/I203238179"]},{"raw_affiliation_string":"Leslie Dan College of Pharmacy, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5080330665"],"corresponding_institution_ids":["https://openalex.org/I185261750","https://openalex.org/I203238179"],"apc_list":{"value":4100,"currency":"USD","value_usd":4100},"apc_paid":null,"fwci":0.4709,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.46876873,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"131","issue":"3","first_page":"165","last_page":"173"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9413999915122986,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9413999915122986,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.04170000180602074,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topical-corticosteroids","display_name":"topical corticosteroids","score":0.9430000185966492},{"id":"https://openalex.org/keywords/emax-model","display_name":"Emax model","score":0.968999981880188},{"id":"https://openalex.org/keywords/potency-assessment","display_name":"potency assessment","score":0.7509999871253967},{"id":"https://openalex.org/keywords/skin-blanching","display_name":"skin blanching","score":0.8550000190734863},{"id":"https://openalex.org/keywords/clobetasol-propionate","display_name":"clobetasol propionate","score":0.9810000061988831},{"id":"https://openalex.org/keywords/mometasone-furoate","display_name":"mometasone furoate","score":1.0},{"id":"https://openalex.org/keywords/cream-formulation","display_name":"cream formulation","score":0.7200000286102295},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.9843075275421143},{"id":"https://openalex.org/C2781348165","wikidata":"https://www.wikidata.org/wiki/Q1044248","display_name":"Mometasone furoate","level":3,"score":0.6923229098320007},{"id":"https://openalex.org/C2776110085","wikidata":"https://www.wikidata.org/wiki/Q421637","display_name":"Clobetasol propionate","level":3,"score":0.6895424723625183},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5518640875816345},{"id":"https://openalex.org/C2776265840","wikidata":"https://www.wikidata.org/wiki/Q4924924","display_name":"Blanching","level":2,"score":0.4728153944015503},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4668721854686737},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.4446552097797394},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34154585003852844},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1526907980442047},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.15092304348945618},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13147664070129395},{"id":"https://openalex.org/C31903555","wikidata":"https://www.wikidata.org/wiki/Q1637030","display_name":"Food science","level":1,"score":0.09985038638114929}],"mesh":[{"descriptor_ui":"D000068656","descriptor_name":"Mometasone Furoate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014662","descriptor_name":"Vasoconstrictor Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bcpt.13759","doi":"https://doi.org/10.1111/bcpt.13759","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcpt.13759","pdf_url":null,"source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},{"id":"doi:10.22541/au.164873495.52129465/v1","doi":"https://doi.org/10.22541/au.164873495.52129465/v1","is_oa":false,"landing_page_url":"https://doi.org/10.22541/au.164873495.52129465/v1","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmid:35639025","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35639025","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic & clinical pharmacology & toxicology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8999999761581421}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W116565362","https://openalex.org/W313155175","https://openalex.org/W909226436","https://openalex.org/W1970473426","https://openalex.org/W1971588998","https://openalex.org/W1979196196","https://openalex.org/W2003510402","https://openalex.org/W2006052678","https://openalex.org/W2011379500","https://openalex.org/W2024652279","https://openalex.org/W2039534486","https://openalex.org/W2050983549","https://openalex.org/W2060604544","https://openalex.org/W2078865702","https://openalex.org/W2086636457","https://openalex.org/W2090437814","https://openalex.org/W2104283436","https://openalex.org/W2349094442","https://openalex.org/W2470769322","https://openalex.org/W2618292589","https://openalex.org/W2889201332","https://openalex.org/W2899645235","https://openalex.org/W2953900013","https://openalex.org/W3087565978","https://openalex.org/W3193127945","https://openalex.org/W3200483736","https://openalex.org/W4231838815","https://openalex.org/W4238989736","https://openalex.org/W4242871825"],"related_works":["https://openalex.org/W4283713460","https://openalex.org/W3200483736","https://openalex.org/W2889789192","https://openalex.org/W1972925703","https://openalex.org/W2034266801","https://openalex.org/W2171360629","https://openalex.org/W2397825700","https://openalex.org/W2022221921","https://openalex.org/W1978345728","https://openalex.org/W2150298541"],"abstract_inverted_index":{"Abstract":[0],"The":[1,44,172],"objective":[2],"of":[3,11,40,46,75,100,114,161,169,174,177,182,189,195],"this":[4],"study":[5,95],"was":[6,121],"to":[7,21,36,71,123,166],"compare":[8],"the":[9,18,23,29,38,73,81,97,111,137,167,175,187,193],"potencies":[10,45,99,176,181],"two":[12,47],"topical":[13,88],"corticosteroid":[14],"products":[15],"(TCPs)":[16],"using":[17,65,105],"Emax":[19],"model":[20],"fit":[22],"skin":[24],"blanching":[25],"responses":[26],"obtained":[27],"from":[28,91],"US":[30],"FDA's":[31],"vasoconstrictor":[32],"assay":[33],"(VCA)":[34],"and":[35,56,77],"illustrate":[37],"influence":[39,74,188],"formulation":[41,76,170,190],"on":[42,192],"potency.":[43],"marketed":[48],"TCPs,":[49],"Dermovate\u00ae":[50],"cream":[51,58],"containing":[52,59,139,152],"clobetasol":[53],"propionate":[54],"(CP)":[55],"Elocon\u00ae":[57],"mometasone":[60],"furoate":[61],"(MF),":[62],"were":[63,83,103],"assessed":[64,104],"healthy":[66],"human":[67],"subjects.":[68],"In":[69],"order":[70],"investigate":[72],"associated":[78],"vehicle":[79],"properties,":[80],"creams":[82],"compared":[84],"with":[85,179],"their":[86,183],"respective":[87],"corticosteroids":[89],"(TCs)":[90],"a":[92,106,142],"previously":[93],"published":[94],"wherein":[96],"inherent":[98,112,180],"those":[101,196],"TCs":[102,185],"validated":[107],"VCA":[108],"method.":[109],"Whereas":[110],"potency":[113,144,162,194],"MF":[115,153],"(Emax":[116,128,145,154],"=":[117,129,146,155],"\u221294.45":[118],"\u00b1":[119,131,148,157],"0.21)":[120],"found":[122],"be":[124,164],"greater":[125],"than":[126,150],"CP":[127,140],"\u221258.80":[130],"15.65),":[132],"when":[133],"formulated":[134],"as":[135],"creams,":[136],"TCP":[138],"had":[141],"higher":[143],"\u221286.15":[147],"0.17)":[149],"that":[151],"\u221242.61":[156],"26.04).":[158],"This":[159],"reversal":[160],"may":[163],"attributed":[165],"effect":[168],"factors.":[171],"comparison":[173],"TCPs":[178],"corresponding":[184],"confirmed":[186],"parameters":[191],"products.":[197]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4281745809","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-06-13T00:00:00"}
